Clinical trialPhase 4Unknown
Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy
Additional Effects of Perioperative Immunonutrition on Th1/Th2 Differentiation in Patients Undergoing Pancreaticoduodenectomy
- Outcome
- Outcome unknown
- Phase
- Phase 4
- Status
- Unknown
- Study type
- Interventional
- Start
- January 2013
- Expected end
- September 2015
- Enrollment
- 60 participants
- Sites
- 1
- Primary outcomes
- plasma resolvin E1, cell-mediated immunity
- Sponsor
- Other
- Results posted
- No
- Last update
- 25 October 2013
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of this study is to investigate whether perioperative immunonutrition has additional effects on cell-mediated immunity in patients undergoing pancreaticoduodenectomy.
Detailed description public domain (ClinicalTrials.gov)
The investigators reported that perioperative immunonutrition had no additional effects compared with preoperative immunonutrition in patients underwent colorectal surgery (Braga M, Gianotti L, Vignali A, Carlo VD. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery. 2002; 132:805-14, PMID: 12464864). Object of this study is to investigate the additional effects of perioperative immunonutrition on cell-mediated immunity and incidence of infectious complication after pancreaticoduodenectomy.